D.E. Shaw & Co’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-960	Closed	-$41K	–	4314
2022 Q2	$41K	Sell	960 -187	-16%	-$7.99K	﹤0.01%	3697
2022 Q1	$78K	Buy	+1,147	New	+$78K	﹤0.01%	3794
2021 Q3	–	Sell	-1,689	Closed	-$464K	–	3979
2021 Q2	$464K	Buy	+1,689	New	+$464K	﹤0.01%	2924